Skip to main content
. 2018 May;4(1):9–13. doi: 10.15420/cfr.2018:10:1

Table 2: Use of Cardiovascular Medications and Devices in Patients with HFmrEF as Reported in Recent Analyses of Data from Clinical Registries.

SwedeHF[11] GWTG-HF[20] CHART-2[13] TIME-CHF[24] MUSIC/REDINSCOR I[23] REDINSCOR II[22] RICA[21]
ACEi/ARB (%) 84 64.7‡ 80.0 90.7 87.2 72.4‡ 79
Beta-blockers (%) 86 78.5‡ 63.8 73.1 76.7 71.8‡ 71.0
MRAS (%) 24 11.9‡ 29.3 33.3 40.0 45.0‡ 41.0
ARNI (%) NA NA NA NA NA NA NA
Ivabradine (%) NA NA NA NA NA NA 1.0
Diuretics (%) 74 46.5‡ 63.3 NA NA NA NA
Loop diuretics (%) NA NA NA 89.8 76.7 NA 93.0
Thiazides (%) NA NA NA NA NA NA 14.0
Digoxin (%) 16 14.8‡ NA 13.9 16.8 NA 25.0
Anticoagulation therapy (%) 38 31.9‡ NA NA NA NA 53.0
Statins (%) 48 55.4* 39.6 NA 59.1 NA NA
Platelet inhibitors (%) 53 45.4† 27.0§ NA 30.2 NA 41.0
Nitrates (%) 17 18.4† NA 32.4 NA NA NA
CRT (%) 0.9 11.5 1.8 NA 4.6 NA NA
ICD (%) 1.3 3.9 3.9 2.8 7.0 NA NA
Vasodilators (%) NA 15.8‡ NA NA NA NA 29.0

*Lipid-lowering medications; †on admission; ‡discharge medication; §aspirin; ACEi = angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI = angiotensin receptor nepriiysin inhibitor; CHART-2 = Chronic Heart Failure Analysis and Registry in the Tohoku District-2 Study; CHF = trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure; CRT = cardiac resynchronisation therapy; GWTG-HF = The Get With The Guidellnes-HF Registry; HFmrEF = heart faiiure with mid-range ejection fraction; ICD = implantable cardioverter-defibrillator; MRA = mineralocorticoid receptor antagonist; NA = data not avaiiable; REDINSCOR II – Red Espan'ola de Insuficiencia Cardiaca researchers; RICA – Spanish National Registry on Heart Failure; SwedeHF = Swedish Heart Failure Registry; TIME-MUSIC/REDINSCORI – MUerte Subita en Insuficiencia Cardiaca/Network for the Study of Heart Failure.